Mifepristone increases the cytotoxicity of uterine natural killer cells by acting as a glucocorticoid antagonist via ERK activation
about
Human Decidual Stromal Cells as a Component of the Implantation Niche and a Modulator of Maternal ImmunitySelective progesterone receptor modulators: an updateDevelopment of a novel anti-human aspartyl-(asparaginyl) β-hydroxylase monoclonal antibody with diagnostic and therapeutic potential.Effects of simulated microgravity on primary human NK cells.A New Ex Vivo Method for Effective Expansion and Activation of Human Natural Killer Cells for Anti-Tumor Immunotherapy.Glucocorticoids and Reproduction: Traffic Control on the Road to Reproduction.Heat shock protein 90 inhibitors induce functional inhibition of human natural killer cells in a dose-dependent manner.Metapristone (RU486 metabolite) suppresses NSCLC by targeting EGFR-mediated PI3K/AKT pathway.11β-HSD1 inhibition ameliorates diabetes-induced cardiomyocyte hypertrophy and cardiac fibrosis through modulation of EGFR activity.Endogenous TWEAK is critical for regulating the function of mouse uterine natural killer cells in an immunological model of pregnancy loss.The immunological effect of Galectin-9/TIM-3 pathway after low dose Mifepristone treatment in mice at 14.5 day of pregnancy.Progesterone Modulation of Pregnancy-Related Immune Responses.
P2860
Q26745137-03835440-5E97-4FAE-BDE6-1FD4D0B7BCBAQ28239255-DF3696F8-10A0-4DD3-81EA-CD6A44795963Q33599455-028BEDA1-53E4-4D95-B443-41D46ACE811BQ37101973-C9D38B2E-1ADE-43B6-85C4-179CABB3BEDDQ38766781-37DDB2D5-F1FF-4EF1-AE29-CCB8390DE392Q39169128-DBB2CE4B-9CB7-4DE8-A242-307C8F2714AAQ42700000-55125421-DE7D-409B-B15C-83580ABEC315Q43987893-AAC93CA4-A8F7-43B8-BC58-CCC86E01D897Q47094783-43F45EAA-36B7-44A3-B1E8-DC457E39E1EFQ47877568-25010DA3-7DB6-447A-BAFC-EC1CD4AE9586Q52642697-1A0158A5-81BE-46A3-B641-CAE300609975Q55436453-FB555CED-62B0-4095-AD7B-C47FAF1F7ED8
P2860
Mifepristone increases the cytotoxicity of uterine natural killer cells by acting as a glucocorticoid antagonist via ERK activation
description
2012 nî lūn-bûn
@nan
2012 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Mifepristone increases the cyt ...... antagonist via ERK activation
@ast
Mifepristone increases the cyt ...... antagonist via ERK activation
@en
Mifepristone increases the cyt ...... antagonist via ERK activation
@nl
type
label
Mifepristone increases the cyt ...... antagonist via ERK activation
@ast
Mifepristone increases the cyt ...... antagonist via ERK activation
@en
Mifepristone increases the cyt ...... antagonist via ERK activation
@nl
prefLabel
Mifepristone increases the cyt ...... antagonist via ERK activation
@ast
Mifepristone increases the cyt ...... antagonist via ERK activation
@en
Mifepristone increases the cyt ...... antagonist via ERK activation
@nl
P2093
P2860
P1433
P1476
Mifepristone increases the cyt ...... antagonist via ERK activation
@en
P2093
Lili Huang
Yaling Zhuang
Yuezhou Chen
P2860
P304
P356
10.1371/JOURNAL.PONE.0036413
P407
P577
2012-05-01T00:00:00Z